EPAM insider files Form 144 to sell 10,079 shares on NYSE
Rhea-AI Filing Summary
EPAM Systems, Inc. filed a Form 144 reporting a proposed sale of 10,079 common shares through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $1,520,533.06. The filing lists the intended sale date as 10/02/2025 on the NYSE and shows 55,696,909 shares outstanding for the class. The shares to be sold were originally acquired through multiple grants of restricted stock that vested on specific dates between 02/02/2021 and 03/15/2025, with individual lots listed and the nature of payment noted as Services Rendered. The filer certifies no undisclosed material adverse information and indicates there were no securities sold by the account holder in the past three months.
Positive
- Form 144 filed with specific broker and sale date details
- 10,079 shares origin documented via restricted stock vesting between 02/02/2021 and 03/15/2025
- Filer states no securities sold in the past three months
Negative
- Insider intends to sell 10,079 shares, representing an indicated disposition of previously restricted compensation
- Filing does not disclose the expected sale price per share
Insights
Insider plans to sell 10,079 shares valued at $1.52M on 10/02/2025.
The filing documents a single proposed block sale executed through Morgan Stanley Smith Barney LLC, providing clear broker and timing details. The shares originate from multiple restricted stock vesting events between 02/02/2021 and 03/15/2025, indicating the position was built from routine compensation, not a recent open-market purchase.
This is a standard Rule 144 notice that enables an insider to sell restricted or control securities; the filing itself does not disclose price or trigger changes in company fundamentals.
Form 144 is properly filed and includes required vesting lot details and the sale broker.
The notice includes the required certification that the filer is unaware of undisclosed material adverse information and notes no sales in the past three months, which aligns with Form 144 disclosure expectations. The detailed acquisition table (dates and lot sizes) supports compliance with Rule 144 aggregation rules.
Monitorable item: the reported approximate sale date is 10/02/2025.